AsOf

Recorded or changed on this day 2026-11-08

45,101–45,150 of 46,534 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 259,276,709 shares
Vertex Pharmaceuticals shares outstanding: 259,276,709 shares, claim clm_987CBFB7A223 · ended · superseded by clm_9BAB61679F38 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 4,162,821,000 United States dollar
Vertex Pharmaceuticals revenue: 4,162,821,000 United States dollar, claim clm_98E5E59F6D9E · ended · superseded by clm_710D5BB40195 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 602,753,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 602,753,000 United States dollar, claim clm_98EA8D3ED9D1 · ended · superseded by clm_CBAB0AE654C4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 204,412,712 shares
Vertex Pharmaceuticals shares outstanding: 204,412,712 shares, claim clm_995698503836 · ended · superseded by clm_AFEA9E22E536 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,645,600,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,645,600,000 United States dollar, claim clm_99B3D838F073 · ended · superseded by clm_85558B741195 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 569,901,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 569,901,000 United States dollar, claim clm_99FB6CAA75AD · ended · superseded by clm_6F397338265E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,230,878,000 United States dollar
Vertex Pharmaceuticals total equity: 1,230,878,000 United States dollar, claim clm_9AE7AF8EC0D1 · ended · superseded by clm_46E7801D804E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · -614,012,000 United States dollar
Vertex Pharmaceuticals operating income: -614,012,000 United States dollar, claim clm_9AF280BB8EE3 · ended · superseded by clm_9472043EC2FF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,964,700,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,964,700,000 United States dollar, claim clm_9B7DD75E016B · ended · superseded by clm_8AB184162D82 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 569,299,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 569,299,000 United States dollar, claim clm_9BA598811A16 · ended · superseded by clm_4CF2DBBF2865 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 260,467,334 shares
Vertex Pharmaceuticals shares outstanding: 260,467,334 shares, claim clm_9BAB61679F38 · ended · superseded by clm_5240C50AF834 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -232,457,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -232,457,000 United States dollar, claim clm_9DB52C5BBEAA · ended · superseded by clm_34EE023B80C3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 516,912,000 United States dollar
Vertex Pharmaceuticals research and development: 516,912,000 United States dollar, claim clm_9DFE9C7313E6 · ended · superseded by clm_7210AEE2240D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 8,133,473,000 United States dollar
Vertex Pharmaceuticals total equity: 8,133,473,000 United States dollar, claim clm_9E3B341B6DD1 · ended · superseded by clm_12C888060D24 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,096,346,000 United States dollar
Vertex Pharmaceuticals total equity: 1,096,346,000 United States dollar, claim clm_9E65725B61EB · ended · superseded by clm_19213C00D007 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 18,150,900,000 United States dollar
Vertex Pharmaceuticals total assets: 18,150,900,000 United States dollar, claim clm_9F22DDDCD1C9 · ended · superseded by clm_FF4FA49D5268 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 2,028,579,000 United States dollar
Vertex Pharmaceuticals total equity: 2,028,579,000 United States dollar, claim clm_A0081165ACC0 · ended · superseded by clm_A9DE66326560 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,334,300,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,334,300,000 United States dollar, claim clm_A07370340B6C · ended · superseded by clm_56F24DCACD81 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 23,795,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 23,795,000 United States dollar, claim clm_A2ABBC5D4946 · ended · superseded by clm_06E54341B7F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 255,559,939 shares
Vertex Pharmaceuticals shares outstanding: 255,559,939 shares, claim clm_A2CE75CC8517 · ended · superseded by clm_D3864179769E · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · research and development · 3,051,100,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · -903,448,000 United States dollar
Vertex Pharmaceuticals operating income: -903,448,000 United States dollar, claim clm_A3A048BBF066 · ended · superseded by clm_729B31AEC767 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,345,843,000 United States dollar
Vertex Pharmaceuticals total assets: 2,345,843,000 United States dollar, claim clm_A3EAB937180F · ended · superseded by clm_D1DAC76653E3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 8,980,254,000 United States dollar
Vertex Pharmaceuticals total equity: 8,980,254,000 United States dollar, claim clm_A498CCC0EE53 · ended · superseded by clm_A83B0E7547F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 143,370,000 United States dollar
Vertex Pharmaceuticals revenue: 143,370,000 United States dollar, claim clm_A50C566EACEB · ended · superseded by clm_EDAEC8A3D536 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · headquarters · Boston
Vertex Pharmaceuticals headquarters: Boston, claim clm_A5822A229828 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,156,582,000 United States dollar
Vertex Pharmaceuticals total equity: 1,156,582,000 United States dollar, claim clm_A595BC2C5630 · ended · superseded by clm_B3CDEA1413F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 128,901,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 128,901,000 United States dollar, claim clm_A620E2C8FB71 · ended · superseded by clm_61C96CE7DB96 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -70,026,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -70,026,000 United States dollar, claim clm_A645F319F190 · ended · superseded by clm_6D374A34EDA7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 155,082,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 155,082,000 United States…, claim clm_A76FEE254CA5 · ended · superseded by clm_D6506FFCBC0C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 9,196,396,000 United States dollar
Vertex Pharmaceuticals total equity: 9,196,396,000 United States dollar, claim clm_A83B0E7547F1 · ended · superseded by clm_B630EC176E52 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 420,558,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 420,558,000 United States dollar, claim clm_A8C0C28AF1BF · ended · superseded by clm_B60FF5975D9F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 6,795,000,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 6,795,000,000 United States dollar, claim clm_A982731934E0 · ended · superseded by clm_AAF7A5074870 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 245,717,286 shares
Vertex Pharmaceuticals shares outstanding: 245,717,286 shares, claim clm_A9C81118AB1C · ended · superseded by clm_E922A99A9EA6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 2,401,056,000 United States dollar
Vertex Pharmaceuticals total equity: 2,401,056,000 United States dollar, claim clm_A9DE66326560 · ended · superseded by clm_BDF180B6AD97 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 2,893,885,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 2,893,885,000 United States dollar, claim clm_AA625CEFE3E2 · ended · superseded by clm_73E5227A4A27 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 208,566,194 shares
Vertex Pharmaceuticals shares outstanding: 208,566,194 shares, claim clm_AA7202AF1645 · ended · superseded by clm_E8ED2497AD7B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 7,600,100,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 7,600,100,000 United States dollar, claim clm_AAF7A5074870 · ended · superseded by clm_2EBAE376F4A3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 247,778,698 shares
Vertex Pharmaceuticals shares outstanding: 247,778,698 shares, claim clm_AAFEE05A628C · ended · superseded by clm_E95980D51DAA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 957,079,000 United States dollar
Vertex Pharmaceuticals total equity: 957,079,000 United States dollar, claim clm_AB61E3D00C03 · ended · superseded by clm_E3F59624DB5A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 256,390,651 shares
Vertex Pharmaceuticals shares outstanding: 256,390,651 shares, claim clm_ABBFFDB9DFAC · ended · superseded by clm_663C199EF289 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 503,973,000 United States dollar
Vertex Pharmaceuticals total equity: 503,973,000 United States dollar, claim clm_ABDC2E967578 · ended · superseded by clm_6FF0398AE57E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 8,930,700,000 United States dollar
Vertex Pharmaceuticals revenue: 8,930,700,000 United States dollar, claim clm_AC7CF3A293FF · ended · superseded by clm_6755CB60586A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 249,068,782 shares
Vertex Pharmaceuticals shares outstanding: 249,068,782 shares, claim clm_AC9B824300B5 · ended · superseded by clm_096340916E85 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 3,593,412,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 3,593,412,000 United States dollar, claim clm_AC9CCBAF0908 · ended · superseded by clm_6915B8D4ABB5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 271,295,000 United States dollar
Vertex Pharmaceuticals total equity: 271,295,000 United States dollar, claim clm_ACFA9A6B78BD · ended · superseded by clm_393679081B64 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -161,893,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -161,893,000 United States dollar, claim clm_ADBE4057ECC4 · ended · superseded by clm_21238AD57FDF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 2,145,359,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 2,145,359,000 United States dollar, claim clm_ADD73E1FB943 · ended · superseded by clm_8F818D2E2F7B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 22,880,500,000 United States dollar
Vertex Pharmaceuticals total assets: 22,880,500,000 United States dollar, claim clm_AE9230AA7FE8 · ended · superseded by clm_68305CEE2495 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 14,256,100,000 United States dollar
Vertex Pharmaceuticals total assets: 14,256,100,000 United States dollar, claim clm_AEC6A8645EE2 · ended · superseded by clm_09D1A8C06700 · 1 source (1 primary) · conf 0.95

What the statuses mean